Malachite Innovations, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VBIO research report →
Companywww.malachiteinnovations.com
Vitality Biopharma, Inc. engages in the development of cannabinoid pharmaceuticals for the treatment of inflammatory disorders in the United States. The company is developing tetrahydrocannabinol glycoside (VBX-100), an oral cannabinoid prodrug for inflammatory bowel disease and irritable bowel syndromes.
- CEO
- Michael R. Cavanaugh CPA,
- IPO
- 2008
- Employees
- 3
- HQ
- Los Angeles, CA, US
Price Chart
Valuation
- Market Cap
- $3.48M
- P/E
- 2.76
- P/S
- 8.65
- P/B
- 1.66
- EV/EBITDA
- 2.18
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 25.75%
- Op Margin
- -75.92%
- Net Margin
- 311.28%
- ROE
- 91.35%
- ROIC
- -2.52%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-880,851 · 79.82%
- EPS
- $-0.02 · 79.86%
- Op Income
- $-2,338,213
- FCF YoY
- 55.30%
Performance & Tape
- 52W High
- $5.60
- 52W Low
- $0.72
- 50D MA
- $0.99
- 200D MA
- $1.96
- Beta
- 1.87
- Avg Volume
- 305.23K
Get TickerSpark's AI analysis on VBIO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 1, 26 | Lackey Melinda | other | 45,000 |
| May 1, 26 | Lackey Melinda | other | 0 |
| Jul 29, 21 | LoConti Joseph E. | buy | 1,000 |
| Jul 20, 21 | LoConti Joseph E. | buy | 13,000 |
| Jul 19, 21 | LoConti Joseph E. | buy | 20,000 |
| Jul 19, 21 | LoConti Joseph E. | buy | 67,000 |
| Jul 19, 21 | LoConti Joseph E. | buy | 40,000 |
| Jul 9, 21 | LoConti Joseph E. | buy | 20,000 |
| May 11, 21 | LoConti Joseph E. | buy | 10,000 |
| May 11, 21 | LoConti Joseph E. | buy | 10,000 |
Our VBIO Coverage
We haven't published any research on VBIO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate VBIO Report →